secwatch.observer — SEC 8-K summary
======================================

Issuer:     MACROGENICS INC (MGNX)
CIK:        0001125345
Form:       8-K
Filed at:   2026-07-07T20:30:13+00:00
Accession:  0001125345-26-000045
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 2.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MacroGenics completes $122.5M sale of GMP manufacturing to Bora Pharmaceuticals
-------------------------------------------------------------------------------

- Closed sale of GMP manufacturing (CDMO) to Bora Pharmaceuticals for $122.5M cash, subject to post-closing adjustments.
- Bora assumes Rockville, MD facility and Frederick, MD warehouse; ~140 former MacroGenics employees hired by Bora.
- MacroGenics enters supply agreement with Bora for process development and drug substance production for pipeline.
- Pro forma cash and equivalents rise to $177.2M from $66.5M; estimated gain on sale of $106.1M recorded.
- Up to $5M in contingent consideration possible upon manufacturing milestones in 2027-2028.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1125345/000112534526000045/0001125345-26-000045-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1125345/000112534526000045/mgnx-20260630.htm
  HTML page:      https://secwatch.observer/filing/0001125345-26-000045

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer